Lv32
215 积分 2022-04-19 加入
Abstract CT255: AdvanTIG-204: A phase 2, multicenter, randomized, 3-arm, open-label study investigating the preliminary efficacy and safety of ociperlimab (anti-TIGIT) + tislelizumab (anti-PD-1) + concurrent chemoradiotherapy (cCRT) in patients with untreated limited-stage small cell lung cancer (SCLC)
7小时前
求助中
NRG Oncology/Alliance LU005: A Phase II/III Randomized Study of Chemoradiation vs. Chemoradiation Plus Atezolizumab in Limited Stage Small Cell Lung Cancer
7小时前
已完结
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial
7小时前
已完结
Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small-cell lung cancer: a brief report from the CONVERT trial
7小时前
已完结
Low‐dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives
1天前
已完结
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation
1天前
已完结
The role of prokinetics in managing gastrointestinal involvement in systemic sclerosis: a systematic literature review
6天前
已完结
[Pharmacologic and clinical differentiation of prokinetic drugs]
6天前
已关闭
Prokinetics and their use in gastroenterology
6天前
已关闭
[Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)]
6天前
已关闭
皖公网安备34019202002308
